Am­gen ax­es 149 of its staff in Cam­bridge of­fice; Evotec, Mil­li­pore­Sig­ma en­ter re­search pact

→ Am­gen has sub­mit­ted a Work­er Ad­just­ment and Re­train­ing Act (WARN) — a warn­ing of im­pend­ing mass lay­offs 60 days in ad­vance of the date — to the state of Mass­a­chu­setts in the wake of the com­pa­ny’s ex­o­dus from the neu­ro­sciences R&D sec­tor. Bob Brad­way, CEO of the com­pa­ny, said in a Q3 earn­ings call that the com­pa­ny is cut­ting ties in the field to fo­cus on its oth­er pipelines in car­dio­vas­cu­lar dis­ease, in­flam­ma­to­ry dis­ease and car­dio­vas­cu­lar dis­ease, on­col­o­gy. In its WARN no­tice, the Cam­bridge-based com­pa­ny stat­ed that 149 of its em­ploy­ees would be af­fect­ed — among the to­tal 180 be­ing let go. The com­pa­ny said that im­pact­ed em­ploy­ees, who are not re­lo­cat­ing, will be de­part­ing the com­pa­ny be­tween the end of 2019 to mid-2020.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER